Lawmakers Seek Input On Dx Regs, With Lab-Developed Tests In Focus
This article was originally published in The Gray Sheet
Executive Summary
The House Energy and Commerce Committee is seeking feedback on legislative initiatives Congress should enact in 2015 regarding regulation of diagnostics, and in particular in response to FDA's plan to regulate laboratory developed tests.